Five‐year efficacy and safety of tenofovir‐based salvage therapy for patients with chronic hepatitis B who previously failed <scp>LAM</scp>/<scp>ADV</scp> therapyLucy Lim, Peter Angus, Scott J. Patterson et al.|Liver International|2016Cited by 14